Massachusetts S1635 authorizes pharmacists to provide opioid use disorder treatment.

Massachusetts S1635 allows pharmacists in retail settings with a collaborative practice agreement to prescribe controlled substances for opioid use disorder treatment. These pharmacists must have a specific agreement with supervising physicians allowing initial prescriptions for referred patients. The bill outlines settings where collaborative drug therapy management is allowed, including hospitals, long-term care facilities, and hospice settings. A copy of the prescription must be sent to the supervising physician within 24 hours.

Massachusetts S1635 authorizes pharmacists to provide opioid use disorder treatment.

Massachusetts S1635 allows pharmacists in retail settings with a collaborative practice agreement to prescribe controlled substances for opioid use disorder treatment. These pharmacists must have a specific agreement with supervising physicians allowing initial prescriptions for referred patients. The bill outlines settings where collaborative drug therapy management is allowed, including hospitals, long-term care facilities, and hospice settings. A copy of the prescription must be sent to the supervising physician within 24 hours.